Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Wich

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Future Medicinal Chemistry|October 1, 2021
Can dextran-based nanoparticles mitigate inflammatory lung diseases?Parteek Prasher, Mousmee Sharma, Peter R Wich, et al.
Bioconjugate Chemistry|May 5, 2011
Acid-degradable cationic dextran particles for the delivery of siRNA therapeuticsJessica L Cohen, Stephanie Schubert, Peter R Wich, et al.
Journal of Colloid and Interface Science|May 26, 2020
Metal-organic frameworks as protective matrices for peptide therapeuticsJian Liu, Ziyi Guo, Marija Kordanovski, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 17, 2018
Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulationDavid Paßlick, Keti Piradashvili, Denise Bamberger, et al.
Chemmedchem|March 3, 2020
Asymmetric Disulfanylbenzamides as Irreversible and Selective Inhibitors of Staphylococcus aureus Sortase AFabian Barthels, Gabriella Marincola, Tessa Marciniak, et al.
Nanomedicine (London, England)|September 16, 2016
Dextran-based therapeutic nanoparticles for hepatic drug deliveryFriedrich Foerster, Denise Bamberger, Jonathan Schupp, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 27, 2020
Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectivesMeenu Mehta, Saurabh Satija, Keshav R Paudel, et al.
Journal of the American Chemical Society|June 28, 2016
Quantum Chemical-Based Protocol for the Rational Design of Covalent InhibitorsTanja Schirmeister, Jochen Kesselring, Sascha Jung, et al.
Chemico-Biological Interactions|May 8, 2020
Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspectiveParteek Prasher, Mousmee Sharma, Meenu Mehta, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 CellsKeshav Raj Paudel, Nisha Panth, Bikash Manandhar, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Future Medicinal Chemistry|October 1, 2021
Can dextran-based nanoparticles mitigate inflammatory lung diseases?Parteek Prasher, Mousmee Sharma, Peter R Wich, et al.
Bioconjugate Chemistry|May 5, 2011
Acid-degradable cationic dextran particles for the delivery of siRNA therapeuticsJessica L Cohen, Stephanie Schubert, Peter R Wich, et al.
Journal of Colloid and Interface Science|May 26, 2020
Metal-organic frameworks as protective matrices for peptide therapeuticsJian Liu, Ziyi Guo, Marija Kordanovski, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 17, 2018
Delivering all in one: Antigen-nanocapsule loaded with dual adjuvant yields superadditive effects by DC-directed T cell stimulationDavid Paßlick, Keti Piradashvili, Denise Bamberger, et al.
Chemmedchem|March 3, 2020
Asymmetric Disulfanylbenzamides as Irreversible and Selective Inhibitors of Staphylococcus aureus Sortase AFabian Barthels, Gabriella Marincola, Tessa Marciniak, et al.
Nanomedicine (London, England)|September 16, 2016
Dextran-based therapeutic nanoparticles for hepatic drug deliveryFriedrich Foerster, Denise Bamberger, Jonathan Schupp, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 27, 2020
Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectivesMeenu Mehta, Saurabh Satija, Keshav R Paudel, et al.
Journal of the American Chemical Society|June 28, 2016
Quantum Chemical-Based Protocol for the Rational Design of Covalent InhibitorsTanja Schirmeister, Jochen Kesselring, Sascha Jung, et al.
Chemico-Biological Interactions|May 8, 2020
Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspectiveParteek Prasher, Mousmee Sharma, Meenu Mehta, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 CellsKeshav Raj Paudel, Nisha Panth, Bikash Manandhar, et al.
Pageof 4